Postpartum Vaginal Blood Loss following Two Different Methods of Cervical Ripening

Eighty women undergoing induction of labor at the University of Calabar Teaching Hospital were recruited and randomly allocated into two treatment groups (40 each), to receive either serial 50 µg doses of misoprostol or intracervical Foley catheter. Vaginal blood loss was collected and measured usin...

Full description

Saved in:
Bibliographic Details
Main Authors: Okon Asuquo Okon (Author), John Egede Ekabua (Author)
Format: Book
Published: Hindawi Limited, 2017-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_723f7c6a87db47868c9991b4dbc93ed6
042 |a dc 
100 1 0 |a Okon Asuquo Okon  |e author 
700 1 0 |a John Egede Ekabua  |e author 
245 0 0 |a Postpartum Vaginal Blood Loss following Two Different Methods of Cervical Ripening 
260 |b Hindawi Limited,   |c 2017-01-01T00:00:00Z. 
500 |a 1687-9589 
500 |a 1687-9597 
500 |a 10.1155/2017/1678265 
520 |a Eighty women undergoing induction of labor at the University of Calabar Teaching Hospital were recruited and randomly allocated into two treatment groups (40 each), to receive either serial 50 µg doses of misoprostol or intracervical Foley catheter. Vaginal blood loss was collected and measured using an under buttocks plastic collection bag and by perineal pad weighing up to 6 hours postpartum. There were no significant differences between the two groups with respect to sociodemographic and obstetric characteristics. Comparison of blood loss in vaginal deliveries between the two groups revealed that subjects in the misoprostol group had significantly higher blood loss than subjects in the Foley catheter group (488 ± 222 versus 326 ± 106, p<0.05). In both groups, there was strong and statistically significant positive correlation between postpartum blood loss and induction delivery interval (r=0.75, p<0.0001; r=0.77, p<0.0001). There were no significant differences in maternal outcomes. In view of this, further study is required to ascertain if lower doses of misoprostol for induction of labor may result in lesser blood loss. This trial is registered with ISRCTN14479515. 
546 |a EN 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Obstetrics and Gynecology International, Vol 2017 (2017) 
787 0 |n http://dx.doi.org/10.1155/2017/1678265 
787 0 |n https://doaj.org/toc/1687-9589 
787 0 |n https://doaj.org/toc/1687-9597 
856 4 1 |u https://doaj.org/article/723f7c6a87db47868c9991b4dbc93ed6  |z Connect to this object online.